Taysha Gene Therapies (TSHA) Earnings Date & Reports

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TSHA is expected to report earnings to rise 5.67% to -12 cents per share on November 10

Taysha Gene Therapies TSHA Stock Earnings Reports

Q3'26

Est.

$-0.13

Q1'26

Missed

by $0.02

Q4'25

Beat

by $0.02

Q3'25

Est.

$-0.09

Q2'25

Missed

by $0.01

The last earnings report on May 06 showed earnings per share of -11 cents, missing the estimate of -10 cents. With 1.10M shares outstanding, the current market capitalization sits at 1.81B.

View a ticker or compare two or three

TSHA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days